MCID: MLL004
MIFTS: 22

Mallory-Weiss Syndrome malady

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Mallory-Weiss Syndrome

About this section

Aliases & Descriptions for Mallory-Weiss Syndrome:

Name: Mallory-Weiss Syndrome 45 65
Mucosal Lacerations - Gastroesophageal Junction 45
Gastroesophageal Laceration-Hemorrhage 45
 
Mallory-Weiss Laceration 45
Mallory-Weiss Tear 45

Classifications:



External Ids:

UMLS65 C0024633

Summaries for Mallory-Weiss Syndrome

About this section
Wikipedia:68 Mallory–Weiss syndrome or gastro-esophageal laceration syndrome refers to bleeding from a laceration... more...

MalaCards based summary: Mallory-Weiss Syndrome, also known as mucosal lacerations - gastroesophageal junction, is related to rheumatoid arthritis and arthritis. Affiliated tissues include t cells, lung and heart.

Related Diseases for Mallory-Weiss Syndrome

About this section

Graphical network of the top 20 diseases related to Mallory-Weiss Syndrome:



Diseases related to mallory-weiss syndrome

Symptoms for Mallory-Weiss Syndrome

About this section

Drugs & Therapeutics for Mallory-Weiss Syndrome

About this section

Drugs for Mallory-Weiss Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Metoclopramideapproved, investigationalPhase 4102364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
KBio2_004686
 
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metonia
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
2
DopamineapprovedPhase 4308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3
OndansetronapprovedPhase 428599614-02-54595
Synonyms:
(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one
1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one
103639-04-9 (mono-hydrochloride dihydrate)
108303-49-7
116002-70-1
9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
99614-01-4 (mono-hydrochloride)
99614-02-5
AB00373674
AC1L1IIM
AKOS000599484
Apo-ondansetron
BAS 00717177
BPBio1_001118
BRD-A19736161-001-01-8
BRD-A19736161-003-03-0
BRN 3622981
BSPBio_001016
C07325
C18H19N3O
CBDivE_008994
CHEMBL46
CID4595
CPD001307702
D00456
DB00904
DESMETHYLONDANSETRON
GR 38032
GR 38032X
GR-38032F
GR38032F
HMS2090H16
I06-0687
I06-1329
L000456
 
LS-172305
LS-51878
MolPort-001-944-253
NCI60_022780
Novo-ondansetron
Ondansetron
Ondansetron (JAN/USP/INN)
Ondansetron Hydrochloride
Ondansetron [USAN:INN:BAN]
Ondansetron hydrochloride dihydrate
Ondansetron, (+,-)-Isomer
Oprea1_435466
Oprea1_852372
PHL-ondansetron
PMS-ondansetron
Prestwick0_001058
Prestwick1_001058
Prestwick2_001058
Prestwick3_001058
Ratio-ondansetron
SAM002589958
SN-307
SPBio_002938
STK370548
STOCK4S-10990
Sandoz ondansetron
TL8006071
TimTec1_001750
UNII-4AF302ESOS
ZOFRAN IN PLASTIC CONTAINER
Zofran
Zofran ODT
Zofran ODT (TN)
Zofran odt
Zophren
Zudan
Zuplenz
ondansetron
ondansetron (Zofran)
4Neurotransmitter AgentsPhase 414795
5Peripheral Nervous System AgentsPhase 418510
6
SerotoninPhase 4314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
7Tranquilizing AgentsPhase 43597
8Serotonin AntagonistsPhase 41175
9Serotonin AgentsPhase 42668
10Psychotropic DrugsPhase 45501
11Dopamine D2 Receptor AntagonistsPhase 4258
12Antipsychotic AgentsPhase 42130
13AntipruriticsPhase 4619
14AntiemeticsPhase 43213
15Central Nervous System DepressantsPhase 410016
16Dermatologic AgentsPhase 44555
17Anti-Anxiety AgentsPhase 41529
18Dopamine AntagonistsPhase 4927
19Dopamine AgentsPhase 43084
20Gastrointestinal AgentsPhase 46401

Interventional clinical trials:

idNameStatusNCT IDPhase
1Uncomplicated Nausea and Vomiting in the Emergency DepartmentCompletedNCT00778011Phase 4

Search NIH Clinical Center for Mallory-Weiss Syndrome

Genetic Tests for Mallory-Weiss Syndrome

About this section

Anatomical Context for Mallory-Weiss Syndrome

About this section

MalaCards organs/tissues related to Mallory-Weiss Syndrome:

33
T cells, Lung, Heart, Brain, Endothelial, Bone, Liver

Animal Models for Mallory-Weiss Syndrome or affiliated genes

About this section

Publications for Mallory-Weiss Syndrome

About this section

Articles related to Mallory-Weiss Syndrome:

(show top 50)    (show all 155)
idTitleAuthorsYear
1
Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2. (27045964)
2016
2
Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition. (24981670)
2014
3
Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways. (25302307)
2014
4
Miscellaneous conditions of the peritoneal cavity--peritoneal tumors, pseudomyxoma, mesothelioma, fibroblastic reaction, cocoon, cystic lymphatic malformations, blue-bleb, and chylous ascites. (25459443)
2014
5
Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus. (24990863)
2014
6
Advantages of collagen based biological dressings in the management of superficial and superficial partial thickness burns in children. (24133405)
2013
7
Clinicopathological correlation of parapapillary atrophy in monkeys with experimental glaucoma and temporary central retinal artery occlusion. (23619503)
2013
8
Infantile neuroblastoma of the urinary bladder detected by hematuria. (23543098)
2013
9
Clinical implications of fibroblast activation protein-I+ in non-small cell lung cancer after curative resection: a new predictor for prognosis. (23835897)
2013
10
Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. (23184698)
2013
11
The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy. (22922889)
2012
12
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells. (24057048)
2012
13
Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury. (22049214)
2012
14
Laser ablation of placental vessels in twin-to-twin transfusion syndrome: a paradigm for endoscopic fetal surgery. (21854207)
2011
15
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. (21303861)
2011
16
Identification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancer. (20927484)
2011
17
Prenatal diagnosis of osteogenesis imperfecta type II by three-dimensional ultrasound and computed tomography. (21450031)
2011
18
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. (19734132)
2010
19
Corneal endotheliitis with quantitative polymerase chain reaction positive for human herpesvirus 7. (20385952)
2010
20
Structural polymorphism and multifunctionality of myelin basic protein. (19642704)
2009
21
Effect and mechanism of nociceptin/orphanin FQ reversing multi-drug resistance in K562/ADM cell. (18819522)
2008
22
Isolation of lactoferrin from milk of different species: calorimetric and antimicrobial studies. (18387837)
2008
23
Efficacy of plant sterols is not influenced by dietary cholesterol intake in hypercholesterolemic individuals. (18249205)
2008
24
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. (18591412)
2008
25
The histamine N-methyltransferase T105I polymorphism affects active site structure and dynamics. (18154359)
2008
26
E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib. (18202784)
2008
27
A ligation assay for multiplex analysis of CpG methylation using bisulfite-treated DNA. (17998253)
2007
28
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib. (17956080)
2007
29
Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder. (16691126)
2006
30
Cyclooxygenase-2 inhibitors and cardiovascular risk. (17053413)
2006
31
Ultrastructural studies of Henneguya rhamdia n. sp. (Myxozoa) a parasite from the Amazon teleost fish, Rhamdia quelen (Pimelodidae). (16313446)
2005
32
Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. (15187156)
2004
33
The expression of PPAR gamma in experimental fatty liver disease]. (15268815)
2004
34
Systemic autonomic function in subjects with primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease presentation. (15068428)
2004
35
Gene symbol: ATP7A. Disease: Menkes disease. (15176369)
2004
36
Megaloblastic anemia--Part II. (15286425)
2004
37
Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. (12470302)
2002
38
Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia and occlusive retinal vascular disease in type 2 diabetic and non-diabetic subjects. (12356186)
2002
39
Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis. (12044982)
2002
40
Chemoenzymatic iterative synthesis of difficult linkages of oligosaccharides on soluble polymeric supports. (11594810)
2001
41
Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. (11181645)
2001
42
The search for the MEN1 gene. The European Consortium on MEN-1. (9681841)
1998
43
E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. (9298817)
1997
44
ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. (8692921)
1996
45
Specific loss of protein kinase activities in senescent erythrocytes. (8695869)
1996
46
Efficient approach to synthesis of two-chain asymmetric cysteine analogs of receptor-binding region of transforming growth factor-alpha. (1428535)
1992
47
Integration of a group I intron into a ribosomal RNA sequence promoted by a tyrosyl-tRNA synthetase. (1658660)
1991
48
Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. (2137842)
1990
49
Lipid storage myopathy associated with recurrent Reye syndrome-like attacks, but with a normal carnitine level. (3389475)
1988
50
Central angiospastic retinopathy and central serous chorioretinitis. (13394600)
1957

Variations for Mallory-Weiss Syndrome

About this section

Expression for genes affiliated with Mallory-Weiss Syndrome

About this section
Search GEO for disease gene expression data for Mallory-Weiss Syndrome.

Pathways for genes affiliated with Mallory-Weiss Syndrome

About this section

GO Terms for genes affiliated with Mallory-Weiss Syndrome

About this section

Sources for Mallory-Weiss Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet